-
-
-
-
-
-
-
Sun Pharma signs Definitive Agreement to Acquire Organon
-
-
-
-
-
-
-
Altius Provides 3rd Quarter 2025 Project Generation Update
-
-
-
-
-
-
-
Berger Montague Reminds Organon & Co. (OGN) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by July 22, 2025
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
-
-
-
-
-
-
-
OGN SHAREHOLDER NEWS: Organon & Co. Investors that Incurred Losses are Urged to Contact BFA Law before the July 22 Class Action Deadline
-
-
-
-
-
-
-
ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
-
-
-
-
-
-
-
Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain
-
1,170,148 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

